ctrl K

AI Score

Unlock

Rani Therapeutics Inc. (RANI)

AI Score

Unlock

1.46

-0.07 (-4.58%)

At close: Mar 03, 2025, 3:59 PM

1.47

0.68%

After-hours: Mar 03, 2025, 04:00 PM EST

Rani Therapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	n/a	n/a	2.72M	462K	979K
Cost of Revenue	822K	1.31M	n/a	n/a	n/a
Gross Profit	-822K	-1.31M	2.72M	462K	979K
Operating Income	-66.1M	-63.45M	-51.6M	-16.54M	-27.07M
Interest Income	3.3M	1.25M	89K	63K	423K
Pretax Income	-67.88M	-63.27M	-53.05M	-16.67M	-26.59M
Net Income	-33.97M	-63.34M	-53.09M	-16.7M	-26.6M
Selling & General & Admin	26.48M	26.84M	27.83M	4.96M	3.46M
Research & Development	39.62M	36.61M	26.48M	12.04M	24.58M
Other Expenses	n/a	n/a	n/a	n/a	n/a
Operating Expenses	66.1M	63.45M	54.32M	17.01M	28.04M
Interest Expense	5.08M	1.07M	466K	124K	10K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	66.1M	63.45M	54.32M	17.01M	28.04M
Income Tax	n/a	70K	41K	35K	10K
Shares Outstanding (Basic)	25.5M	23.82M	19.71M	19.74M	19.74M
Shares Outstanding (Diluted)	25.5M	23.82M	19.71M	19.74M	19.74M
EPS (Basic)	-1.33	-2.66	-2.69	-0.85	-1.35
EPS (Diluted)	-1.33	-2.66	-2.69	-0.85	-1.35
EBITDA	-65.28M	-60.89M	-52.08M	-15.96M	-26.01M
Depreciation & Amortization	822K	1.31M	497K	589K	564K